FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3161465498> ?p ?o ?g. }

• W3161465498 endingPage "52" @default.
• W3161465498 startingPage "45" @default.
• W3161465498 abstract "Clinical significance of anti-Ro52 antibodies in connective tissue diseases (CTD) is controversial. Anti-Ro52 antibodies might be associated with a more severe CTD phenotype, especially interstitial lung disease (ILD). The aims of this study were to evaluate ILD prevalence and severity, the prevalence of micro- or macroangiopathy and CTD-associated cancers in CTD with anti-Ro52 antibodies.CTD patients with anti-Ro52 antibody screening by immunoblot at diagnosis were enrolled. Two groups were retrospectively formed according to the presence of anti-Ro52 antibodies with an unbiased 1:1 matching on CTD types. Unsupervised multiple correspondence analysis and hierarchical clustering analysis were used to aggregate anti-Ro52 positive patients in subgroups.408 CTD patients were included. Anti-Ro52 antibodies were detected in 33 % of CTD patients. Anti-Ro52 antibodies were associated with ILD at CTD diagnosis (47.8% vs. 23.0%, OR 3.3 95% IC 1.4 to 8.0, p = 0.008), even after adjusting for the presence of anti-Ro60 antibodies, especially in patients with antisynthetase syndrome, primary Sjögren syndrome and systemic sclerosis. Micro- or macroangiopathy was more frequent in anti-Ro52 positive CTD patients (18.6% vs. 9.7%, p = 0.02) and CTD patients with anti-Ro52 antibodies experienced more frequent relapses and required more immunosuppressive drugs. Clusters 4 and 5 identified anti-Ro52 positive CTD patients with severe ILD and with clinical features of systemic sclerosis or antisynthetase syndrome respectively.We found that anti-Ro52 antibodies were independently associated with ILD in CTD patients irrespective of CTD type. Anti-Ro52 antibodies could be associated with severity and a more relapsing disease course in CTD patients." @default.
• W3161465498 created "2021-05-24" @default.
• W3161465498 creator A5004326349 @default.
• W3161465498 creator A5008215689 @default.
• W3161465498 creator A5014700089 @default.
• W3161465498 creator A5015344865 @default.
• W3161465498 creator A5018486655 @default.
• W3161465498 creator A5035477169 @default.
• W3161465498 creator A5037741203 @default.
• W3161465498 creator A5048808791 @default.
• W3161465498 creator A5076019275 @default.
• W3161465498 creator A5076472810 @default.
• W3161465498 creator A5089697500 @default.
• W3161465498 date "2021-09-01" @default.
• W3161465498 modified "2023-10-14" @default.
• W3161465498 title "Clinical significance of anti-Ro52 (TRIM21) antibodies in adult patients with connective tissue diseases" @default.
• W3161465498 cites W1605984954 @default.
• W3161465498 cites W184510336 @default.
• W3161465498 cites W1964495124 @default.
• W3161465498 cites W1969108300 @default.
• W3161465498 cites W1982764945 @default.
• W3161465498 cites W2004697839 @default.
• W3161465498 cites W2022058938 @default.
• W3161465498 cites W2075463633 @default.
• W3161465498 cites W2111349115 @default.
• W3161465498 cites W2111914290 @default.
• W3161465498 cites W2125013258 @default.
• W3161465498 cites W2130289080 @default.
• W3161465498 cites W2159860161 @default.
• W3161465498 cites W2164096595 @default.
• W3161465498 cites W2311148180 @default.
• W3161465498 cites W2419582408 @default.
• W3161465498 cites W2606709809 @default.
• W3161465498 cites W2611330109 @default.
• W3161465498 cites W2894488075 @default.
• W3161465498 cites W2903572594 @default.
• W3161465498 cites W2941930820 @default.
• W3161465498 doi "https://doi.org/10.1016/j.ejim.2021.04.020" @default.
• W3161465498 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33972152" @default.
• W3161465498 hasPublicationYear "2021" @default.
• W3161465498 type Work @default.
• W3161465498 sameAs 3161465498 @default.
• W3161465498 citedByCount "9" @default.
• W3161465498 countsByYear W31614654982021 @default.
• W3161465498 countsByYear W31614654982022 @default.
• W3161465498 countsByYear W31614654982023 @default.
• W3161465498 crossrefType "journal-article" @default.
• W3161465498 hasAuthorship W3161465498A5004326349 @default.
• W3161465498 hasAuthorship W3161465498A5008215689 @default.
• W3161465498 hasAuthorship W3161465498A5014700089 @default.
• W3161465498 hasAuthorship W3161465498A5015344865 @default.
• W3161465498 hasAuthorship W3161465498A5018486655 @default.
• W3161465498 hasAuthorship W3161465498A5035477169 @default.
• W3161465498 hasAuthorship W3161465498A5037741203 @default.
• W3161465498 hasAuthorship W3161465498A5048808791 @default.
• W3161465498 hasAuthorship W3161465498A5076019275 @default.
• W3161465498 hasAuthorship W3161465498A5076472810 @default.
• W3161465498 hasAuthorship W3161465498A5089697500 @default.
• W3161465498 hasBestOaLocation W31614654981 @default.
• W3161465498 hasConcept C111368507 @default.
• W3161465498 hasConcept C125533998 @default.
• W3161465498 hasConcept C126322002 @default.
• W3161465498 hasConcept C127313418 @default.
• W3161465498 hasConcept C142724271 @default.
• W3161465498 hasConcept C159654299 @default.
• W3161465498 hasConcept C163764329 @default.
• W3161465498 hasConcept C203014093 @default.
• W3161465498 hasConcept C2776670291 @default.
• W3161465498 hasConcept C2778674544 @default.
• W3161465498 hasConcept C2779017958 @default.
• W3161465498 hasConcept C2779075594 @default.
• W3161465498 hasConcept C2779134260 @default.
• W3161465498 hasConcept C2779625490 @default.
• W3161465498 hasConcept C71924100 @default.
• W3161465498 hasConceptScore W3161465498C111368507 @default.
• W3161465498 hasConceptScore W3161465498C125533998 @default.
• W3161465498 hasConceptScore W3161465498C126322002 @default.
• W3161465498 hasConceptScore W3161465498C127313418 @default.
• W3161465498 hasConceptScore W3161465498C142724271 @default.
• W3161465498 hasConceptScore W3161465498C159654299 @default.
• W3161465498 hasConceptScore W3161465498C163764329 @default.
• W3161465498 hasConceptScore W3161465498C203014093 @default.
• W3161465498 hasConceptScore W3161465498C2776670291 @default.
• W3161465498 hasConceptScore W3161465498C2778674544 @default.
• W3161465498 hasConceptScore W3161465498C2779017958 @default.
• W3161465498 hasConceptScore W3161465498C2779075594 @default.
• W3161465498 hasConceptScore W3161465498C2779134260 @default.
• W3161465498 hasConceptScore W3161465498C2779625490 @default.
• W3161465498 hasConceptScore W3161465498C71924100 @default.
• W3161465498 hasLocation W31614654981 @default.
• W3161465498 hasLocation W31614654982 @default.
• W3161465498 hasLocation W31614654983 @default.
• W3161465498 hasOpenAccess W3161465498 @default.
• W3161465498 hasPrimaryLocation W31614654981 @default.
• W3161465498 hasRelatedWork W141491139 @default.
• W3161465498 hasRelatedWork W1997419721 @default.
• W3161465498 hasRelatedWork W2033970484 @default.
• W3161465498 hasRelatedWork W2099279533 @default.

• next